Literature DB >> 8438408

Do prophylactic antilymphocyte globulins (ALG and OKT3) improve renal transplant survival in recipient and donor high-risk groups?

J M Cecka1, D Gjertson, P I Terasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8438408

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Immunosuppressive preconditioning or induction regimens : evidence to date.

Authors:  Henkie P Tan; Marc C Smaldone; Ron Shapiro
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation.

Authors:  A Tarantino; G Montagnino; C Ponticelli
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

3.  Tolerogenic therapies in transplantation.

Authors:  Eugenia K Page; Wasim A Dar; Stuart J Knechtle
Journal:  Front Immunol       Date:  2012-07-18       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.